Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GRL0617 is a selective and competitive SARS-CoVPLpro and deubiquitinase noncovalent inhibitor(IC50 : 0.6 μM, Ki : 0.49 μM).
説明 | GRL0617 is a selective and competitive SARS-CoVPLpro and deubiquitinase noncovalent inhibitor(IC50 : 0.6 μM, Ki : 0.49 μM). |
ターゲット&IC50 | CLpro (SARS CoV-2):0.6 μM |
分子量 | 304.39 |
分子式 | C20H20N2O |
CAS No. | 1093070-16-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 120 mg/mL (394.23 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GRL0617 1093070-16-6 Cell Cycle/Checkpoint DNA Damage/DNA Repair Microbiology/Virology Ubiquitination SARS-CoV DUB competitive noncovalent inhibitor Inhibitor Deubiquitinase SARS coronavirus GRL-0617 inhibit GRL 0617 DUBs inhibitor